Endo International PLC
NASDAQ:ENDP
Endo International PLC
Operating Income
Endo International PLC
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Endo International PLC
NASDAQ:ENDP
|
Operating Income
$259.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Operating Income
$284.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Operating Income
$518.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
10%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Operating Income
-$137.8m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-11%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Operating Income
-$41.2m
|
CAGR 3-Years
-351%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Operating Income
€12.2m
|
CAGR 3-Years
61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
See Also
What is Endo International PLC's Operating Income?
Operating Income
259.8m
USD
Based on the financial report for Dec 31, 2022, Endo International PLC's Operating Income amounts to 259.8m USD.
What is Endo International PLC's Operating Income growth rate?
Operating Income CAGR 1Y
-67%
Over the last year, the Operating Income growth was -67%.